Psychemedics Corporation (PMD) Reports Improved Q3 Results
Tweet
Share
E-mailGet Alerts PMD Hot Sheet
Price: $2.67 --0%
Financial Fact:
Research & development: 347.97K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research & development: 347.97K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Psychemedics Corporation (NASDAQ: PMD) reported Q3 EPS of $0.21, versus $0.16 reported last year. Revenue for the quarter came in at $6.3 million, versus $5.1 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
